bevacizumab in ovarian cancer
Published 9 years ago • 1.4K plays • Length 8:15Download video MP4
Download video MP3
Similar videos
-
3:42
parp maintenance bevacizumab in ovarian cancer
-
5:41
bevacizumab’s role in recurrent ovarian cancer
-
6:03
gog-0218: frontline bevacizumab in ovarian cancer
-
7:24
ovarian cancer: maintenance following frontline bevacizumab
-
4:54
bevacizumab in recurrent ovarian cancer
-
4:03
upfront bevacizumab in advanced ovarian cancer
-
1:06
dr. jason konner discusses bevacizumab in ovarian cancer
-
1:36
dr. tew evaluates bevacizumab treatment in ovarian cancer
-
6:04
when to add bevacizumab for recurrent ovarian cancer
-
1:05
dr. essel discusses long-term bevacizumab in ovarian cancer
-
7:32
bevacizumab for recurrent ovarian cancer
-
1:19
dr. essel discusses adverse events of bevacizumab in ovarian cancer
-
1:08
dr. burger on the use of bevacizumab in ovarian cancer
-
6:57
bevacizumab in platinum-resistant ovarian cancer
-
2:19
dr. arend on fda approval of frontline bevacizumab in ovarian cancer
-
2:56
patient selection for bevacizumab in ovarian cancer
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer
-
1:40
dr. burger on the toxicity profile of bevacizumab in ovarian cancer
-
1:12
dr. herzog on the optimal use of bevacizumab in patients with ovarian cancer